Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:23 pm Purchase |
2025-02-07 | 13D | Arrowhead Pharmaceuticals, Inc. ARWR |
Sarepta Therapeutics Inc. SRPT |
11,926,301 9.500% |
11,926,301 (New Position) |
Filing History |
| 2025-02-14 09:31 am Purchase |
2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
AVORO CAPITAL ADVISORS LLC | 12,028,552 9.600% |
3,139,664 (+35.32%) |
Filing History |
| 2025-02-05 06:41 am Sale |
2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,016,227 4.800% |
-338,104 (-5.32%) |
Filing History |
| 2024-11-14 09:38 am Purchase |
2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
AVORO CAPITAL ADVISORS LLC | 8,888,888 7.200% |
8,888,888 (New Position) |
Filing History |
| 2024-10-16 09:15 am Sale |
2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,354,331 5.100% |
-470,780 (-6.90%) |
Filing History |
| 2024-04-10 2:03 pm Purchase |
2024-03-28 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 12,404,050 10.010% |
1,731,974 (+16.23%) |
Filing History |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 10,672,076 9.930% |
-158,357 (-1.46%) |
Filing History |
| 2024-01-24 12:57 pm Purchase |
2023-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
6,825,111 6.350% |
854,767 (+14.32%) |
Filing History |
| 2024-01-23 4:14 pm Purchase |
2023-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
13,303,281 12.400% |
592,650 (+4.66%) |
Filing History |
| 2023-06-09 2:15 pm Purchase |
2023-05-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 10,830,433 10.130% |
544,261 (+5.29%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 10,286,172 9.700% |
646,029 (+6.70%) |
Filing History |
| 2023-02-08 10:08 am Purchase |
2022-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
STATE STREET CORP STT |
5,970,344 5.630% |
1,845,874 (+44.75%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
12,710,631 12.000% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
12,710,631 12.000% |
702,568 (+5.85%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 9,640,143 9.220% |
358,592 (+3.86%) |
Filing History |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
12,008,063 11.500% |
0 (Unchanged) |
Filing History |
| 2022-01-25 3:03 pm Sale |
2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
12,008,063 11.500% |
-555,069 (-4.42%) |
Filing History |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
The Vanguard Group | 9,281,551 9.030% |
-515,956 (-5.27%) |
Filing History |
| 2021-01-26 6:52 pm Purchase |
2020-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
BLACKROCK INC BLK |
12,563,132 12.200% |
202,174 (+1.64%) |
Filing History |